Search Results for keywords:"intellectual property"

The U.S. International Trade Commission has begun an investigation following a complaint filed by Synesqo SA, Solvay Specialty Polymers USA LLC, and Solvay Specialty Polymers Italy S.P.A. The complaint claims that certain companies in China are wrongfully importing and selling polyvinylidene fluoride resins in the United States, infringing on specific patent claims. The plaintiffs are asking for the Commission to issue orders to stop these imports and sales. The investigation aims to determine if these claims are valid and if a relevant U.S. industry is significantly impacted or in development.

The Department of the Air Force has announced its intention to grant a partially exclusive patent license to Polaris Sensor Technologies, Inc. for a pioneering invention in imaging technology. The patent involves a new design of microgrid imaging polarimeters that enhance image quality and resolution. Interested parties have 15 days from the publication date to file objections if they believe the license does not comply with regulations. Additional details and procedures for objections are provided, and alternative applications can be considered as valid objections if properly completed and timely submitted.

The United States Patent and Trademark Office (USPTO) has extended the Expanded Collaborative Search Pilot (CSP) program for two more years, lasting until October 31, 2022. This program is a joint effort with the Japan Patent Office (JPO) and the Korean Intellectual Property Office (KIPO) to exchange search results for patent applications before any office issues a decision. The goal is to improve the quality and efficiency of patent examination by sharing these results early in the process. Applicants must meet specific requirements, such as filing complete applications and petitions, to participate in this program, which allows collaboration with multiple international patent offices.

The National Institute of Diabetes and Digestive and Kidney Diseases announced a closed meeting for reviewing grant applications. This meeting, to be held from March 5-7, 2025, will take place virtually and is closed to the public to protect confidential information. The discussions during this meeting may involve sensitive trade secrets, patentable material, or personal information, which necessitates privacy. For any inquiries, contact Charlene J. Repique, Ph.D., the Scientific Review Officer at the National Institutes of Health.

The memorandum outlines the U.S. government's policy to protect American companies from unfair foreign practices, especially in the tech industry. It states that the U.S. will impose tariffs and take other actions against countries that apply discriminatory taxes and regulations that hurt U.S. businesses. The document instructs various U.S. officials, including the Secretary of the Treasury and the Trade Representative, to identify these foreign practices, consider responding to them, and develop strategies to mitigate their impact on American companies. The goal is to enhance the competitiveness of U.S. businesses and prevent foreign countries from exploiting them financially.

The U.S. International Trade Commission has started a formal enforcement proceeding regarding cease and desist orders issued in an investigation about certain blood flow restriction devices. This action relates to the alleged infringement of U.S. patents and trademarks by two companies, Rhino, Inc. from Delaware and Wuxi Emsrun Technology Co., Ltd. from China. Despite previous orders, these companies are accused of continuing to sell products that violate these protections. The Commission will investigate these allegations and determine if any enforcement measures are needed.

The United States Patent and Trademark Office (USPTO) is extending the deadline for public feedback on creating a national campaign to fight counterfeit and pirated products. The original call for comments was published on November 17, 2020, and sought insights from various groups, including those affected by counterfeit sales and public-private campaign experts. Through this notice, individuals have until March 12, 2021, to provide their input on developing strategies, education materials, and alerts to help consumers identify and avoid fake products. This extension aims to give more people the chance to share their thoughts and ideas.

A complaint was filed with the U.S. International Trade Commission by Spanx, LLC of Atlanta, Georgia, alleging patent infringement concerning certain shapewear garments. The commission has decided to investigate whether shapewear products imported into the U.S. infringe on the specified patents and whether there's a U.S. industry being harmed. The parties involved are Spanx, various Chinese companies, and other firms like Honeylove Sculptwear Inc. The commission may issue orders to stop these imports if they find violations of U.S. patent law.

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is considering granting sublicensable patent licenses to Simon Fraser University in Canada and Le Centre National de la Recherche Scientifique in France. These licenses relate to a technology involving fluorescent RNA-fluorophore complexes, useful for studying RNA in live cells. The aim is to consolidate patent rights to expedite the development and marketing of this technology. Interested parties can submit comments or license applications by March 16, 2021, to object to the granting of the exclusive patent license.

NASA plans to grant a patent license to a company called SynMatter LLC for inventions related to anti-corrosion materials. This license could be exclusive, co-exclusive, or partially exclusive, giving SynMatter LLC the right to use these inventions in the U.S. However, NASA invites written objections or competing applications by January 30, 2025, if anyone believes this license should not be granted. This process follows certain U.S. laws and regulations about licensing inventions developed with federal funding.